Sleep, Fatigue, and Dexamethosone in Children With Leukemia
NCT00075101 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 134
Last updated 2008-08-18
Summary
The purpose of this study is to determine the relationship between dexamethosone (steroid) and children's sleep and fatigue.
Conditions
Interventions
- DRUG
-
Dexamethosone
10 day study cycle: 5 day observation pre-steroid,5 day observation post-steroid
Sponsors & Collaborators
-
National Institute of Nursing Research (NINR)
lead NIH
Principal Investigators
-
Pamela S Hinds, PhD · St. Jude Children's Research Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 5 Years
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-09-30
- Primary Completion
- 2006-09-30
- Completion
- 2006-09-30
Countries
- United States
Study Locations
More Related Trials
-
Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
NCT00553059 ·Status: COMPLETED ·Phase: PHASE3
-
Dexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By Surgery
NCT00403065 ·Status: COMPLETED ·Phase: PHASE3
-
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
NCT00424242 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Endocrinological Changes Due to Pre-medications of Chemotherapy in Patients With Breast Cancer
NCT04350229 ·Status: COMPLETED ·Phase: NA
-
Heart Safety Study of Ondansetron in Children Receiving Chemotherapy
NCT01896440 ·Status: WITHDRAWN ·Phase: PHASE4
-
Dexamethasone Regimens for Prophylaxis of Paclitaxel-associated Hypersensitivity Reaction
NCT02349763 ·Status: COMPLETED ·Phase: PHASE3
-
Dexamethasone Dyspnea Study
NCT01670097 ·Status: COMPLETED ·Phase: PHASE2
-
High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Mastectomy
NCT03125941 ·Status: COMPLETED ·Phase: PHASE4
-
Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease
NCT00391170 ·Status: COMPLETED ·Phase: PHASE2
-
Schedules of Dexamethasone in Patients Incorrectly Taking Dexamethasone Premedication (REaCT-dexamethasone)
NCT02815319 ·Status: COMPLETED ·Phase: PHASE4
-
Taste, Smell and Chemotherapy (TASTY)
NCT01641172 ·Status: COMPLETED ·Phase: PHASE4
-
Reducing Dexamethasone Around Docetaxel Infusion
NCT02776436 ·Status: COMPLETED ·Phase: PHASE1
-
Low Dose Versus Usual Dose Dexamethasone for Symptom Control in Children Undergoing Cranial or Craniospinal Radiation
NCT01135550 ·Status: TERMINATED ·Phase: PHASE3
-
Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone
NCT05872893 ·Status: UNKNOWN ·Phase: PHASE3
-
Dexamethasone Therapy for Low Back Pain
NCT02965196 ·Status: UNKNOWN ·Phase: NA
-
Multi-day Doses in Prevention of Nausea and Emesis
NCT00600353 ·Status: COMPLETED ·Phase: PHASE2
-
Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer
NCT02550795 ·Status: COMPLETED ·Phase: NA
-
Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain Tumors
NCT05139043 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Pilot Study to Evaluate the Impact of Dexmedetomidine on Breast Cancer Recurrence After Surgery
NCT03109990 ·Status: COMPLETED ·Phase: NA
-
Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients
NCT01370408 ·Status: COMPLETED ·Phase: PHASE2
-
Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients
NCT04508400 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome
NCT02846493 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Fosaprepitant in Preventing Chemotherapy-induced Vomiting in Children Treated With Medium and High Emetic Chemotherapeutic Drugs
NCT05230654 ·Status: UNKNOWN ·Phase: NA
-
Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy
NCT00429702 ·Status: TERMINATED ·Phase: PHASE2
-
Study of HR20013 for Injection in Patients With Malignant Solid Tumors
NCT05465681 ·Status: COMPLETED ·Phase: PHASE1